The mortality and prognostic factors for patients admitted to the intensive care unit (ICU) with solid tumours are unclear. The aim of this study was to describe demographic, clinical and survival data and to identify factors associated with mortality in critically ill patients with solid tumours. A prospective observational cohort study of 177 critically ill patients with solid tumours admitted to a medical-surgical oncological ICU was undertaken. There were no interventions. Among the admissions, 66% were surgical, 79.7% required mechanical ventilation during their stay in the ICU and 31.6% presented with severe sepsis or septic shock. In a multivariate analysis, independent prognostic factors for in-ICU death were the need for vasopressors (OR: 22.66, 95% confidence interval: 6.09 to 82.22, P <0.001) and the acute physiology and chronic health evaluation (APACHE) II score (OR: 1.92, 95% confidence interval: 1.43 to 2.58, P <0.001). Cox multivariate analysis identified the length of stay in the ICU, Charlson comorbidity index score greater than 2, and the need for vasopressors as independent predictors of death after ICU discharge. The mortality rate in the ICU was 21.4%. Improved outcomes in critically ill cancer patients extended to the subgroup of patients with solid tumours. Independent prognostic factors for in-ICU death were the need for vasopressors and the APACHE II score, while the length of stay in the ICU, Charlson comorbidity index score >2, and the need for vasopressors were independent predictors of death after ICU discharge.
For the past two decades, the nature of cancer treatment has changed dramatically with the introduction of new and intensified treatment protocols and improved supportive care. This has led to improved prognoses and survival times in critically ill cancer patients [1] [2] [3] . Many of these patients require admission to the intensive care unit (ICU) for acute concurrent illness, postoperative care or complications associated with cancer or the cancer therapy 4 . Although the survival of critically ill cancer patients is improving, their mortality remains significantly higher than that of non-cancer patients admitted to the ICU (77 vs 39%, respectively) 3 . Cancer is not a homogenous disease in terms of outcome; solid tumours often have a lesser impact on mortality than haematogenous cancers, and even in the latter group, there is wide variation in the prognoses depending on the exact type of tumour and the treatment stage. This trend is similar in cancer patients admitted to the ICU. In neutropenic critically ill cancer patients, organ failure, but not disease progression, predicts the 30-day mortality 5 . The prognosis of underlying disease is not predictive of ICU mortality in patients with haematological malignancies, although a higher mortality rate in the ICU has been reported for haematological malignancies when compared to solid tumour disease [6] [7] [8] . ICU mortality and prognostic factors for patients with solid tumours who are admitted to the ICU, however, are unclear. Two studies have been reported to date that specifically evaluated the outcomes of these patients 9, 10 . Furthermore, few reports have investigated the prognostic indicators in cancer patients admitted to the ICU 11 , and the data available at ICU admission do not accurately predict the prognosis. The aim of the present study was to describe demographic, clinical, and survival data and to identify factors associated with mortality in critically ill patients with solid tumours admitted to our ICU.
MATeRIAlS AND MeTHODS
A prospective cohort study was performed at the National Cancer Institute, Mexico City, from January to October 2007. The hospital has 130 beds and specialises in the care of patients with cancer. The medical-surgical ICU has six beds that are exclusively for oncology patients, with medical and nursing staff who are qualified in intensive care. At least one intensivist and six nurses are on duty 24 hours per day (eight-hourly shifts). All of the nurses take part in regular training in oncology and intensive care, and the ICU has a nurse to patient ratio of 1:1. Routine clinical rounds, including medical and nursing staff and meetings with oncologists, haematologists, nutritionists, surgeons and infectious disease specialists are carried out each day in the ICU. Approximately 300 patients are admitted to the ICU each year. Decisions to admit a patient to the ICU are usually considered together by the intensivist and the oncologist or surgeon oncologist responsible for the patient. The present study was observational and descriptive. The Institutional Review Board approved this study and the need for informed consent was waived.
During the study period, all patients aged over 16 years with solid tumours requiring ICU admissions were evaluated. Patients admitted for routine postoperative care were excluded from the study. In cases of multiple admissions, only the first was considered. The following variables were collected: age, gender, primary diagnosis for ICU admission, type of malignancy, cancer status, duration of mechanical ventilation, positive end-expiratory pressure (PeeP), the need for vasopressors, the length of stay, treatment (chemotherapy within eight weeks of ICU admission), neutropenia (white blood cells less than 1000 per mm 3 ) and ICU mortality. Key laboratory variables (creatinine, haemoglobin, platelets, total bilirubin and albumin levels) were recorded and comorbidity scores were determined using the Charlson comorbidity index (CCI) 12 . The CCI scores were used to divide the patients into two groups: 0 to 2 and greater than 2. Patients were followed up for a minimum of nine months and up to a maximum of 18 months after discharge from the ICU. The clinical follow-up was performed by reviewing clinical records (electronic patient charts) or contacting patients by telephone to determine the length of survival. The length of stay in the ICU was measured as the number of days from admission to the ICU until discharge from the ICU. The presence of organ dysfunction was assessed using the Sequential Organ Failure Assessment (SOFA) score recorded before admission or on the day of admission to the ICU. The presence of six organ dysfunctions (e.g. cardiovascular, neurological, respiratory, renal, hepatic and coagulation) was assessed using the SOFA score 13, 14 . The presence of each organ dysfunction was defined when the degree of dysfunction was equal to one or more. The mostabnormal value for each clinical and laboratory parameter included in the SOFA system was recorded before admission or on the day of admission to the ICU. The Acute Physiology and Chronic Health evaluation (APACHe) II score was recorded using the worst score for acute physiological variables in the first 24 hours 15 . Acute respiratory distress syndrome was defined based on the American-european consensus conference 16 . Sepsis was defined according to standard criteria 17 . Guidelines for management of severe sepsis and septic shock were used 18 .
Data presentation and statistical analyses
Statistical analyses were performed using the Statistical Package for the Social Sciences software (version 15.0; SPSS, Chicago, Il, USA). Continuous variables are expressed as means ± standard deviation, as medians and interquartile ranges if the distribution was skewed, or as a percentage for categorical variables. Student's t-test or the Mann-Whitney U test were used to compare continuous variables according to the data distribution (normal or non-normal, determined using the Kolmogorov-Smirnov test), and the Chi-squared or Fisher's exact test was used to compare categorical variables. Univariate and multivariate logistic regressions were used to identify factors associated with ICU mortality. For categorical variables with multiple levels, the reference level was set as the one with the lowest probability of the dependent variable. Variables with a P <0.2 in the univariate analysis were entered into the model using a forward stepwise procedure. Results were summarised as odds-ratios (OR) and respective 95% confidence intervals (CI). Possible interactions were tested. The SOFA score was not entered into the multivariable analysis concerning possible co-linearity with the APACHe II score because other independent variables are included in that scoring system (P a O 2 /FiO 2 ratio and creatinine). Two-tailed P values <0.05 were considered statistically significant. The area under the receiver operating characteristic curve was used to evaluate the ability of the model to discriminate between patients who lived and those who died (discrimination) 19 . Goodness-of-fit (Hosmer-lemeshow) was calculated to assess the relevance of the logistic regression model 20 . Survival curves were estimated using the Kaplan-Meier method. The log-rank test was used to compare overall survival data. To examine the univariate effects of ICU admission, clinical characteristics and ICU events on survival after ICU discharge, a Cox proportional hazards model was assumed. This proportional hazards assumption was tested for each characteristic. Thereafter, a Cox proportional hazards multivariate model with backward stepwise variable elimination was constructed 21 . Variables with a P value of <0.2 by univariate analysis were entered into the model. Statistical significance was defined as P <0.05.
RESULTS

Patient characteristics
During the study period, 177 patients were admitted, including 106 women (59.9%), with a median age of 52.4±17.25 years. Of these, 66% were surgical admissions. There were 141 patients (79.7%) who required mechanical ventilation during their stay in the ICU, with a median duration of one day (range 0.5 to 4 days). The median length of stay in the ICU was three days (range 1 to 6 days), and 31.6% of the patients had severe sepsis or septic shock. The most common site of infection was the lung (15.3%), while intra-abdominal infection occurred in 14.7% and skin and soft tissue infection occurred in 1.7% of the patients. Escherichia coli was the most frequently isolated bacterium (5.1%), followed by Pseudomonas aeruginosa and Staphylococcus aureus in 3.4% of patients each.
The clinical characteristics of the patients are shown in Table 1 . Fifty-two (29.4%) patients had a gynaecological malignancy, while the other most common primary cancer sites were the gastrointestinal tract and the head and neck ( complete remission of disease. Only two patients had neutropenia. The median SOFA score was three (range 1 to 8), and 40.7% of the patients had three or more organ dysfunctions on the day of their admission to the ICU. The incidence of organ dysfunction was noted to be more frequent for the respiratory, cardiovascular, and hepatic systems (66.1, 45.8 and 41.8% of cases, respectively).
Factors associated with ICU mortality
The mortality rate in the ICU was 21.4% and increased with the number of failing organs, especially in cases where three or more organs failed (81.6%). The ICU mortality rates for patients who required mechanical ventilation (MV) and for those with sepsis were 26.1% (37/141) and 39.3% (22/56), respectively. Table 3 
Long-term outcome of ICU survivors
Of the 139 patients discharged from the ICU (Figure 1 ), long-term follow-up was performed for 120 (86.3%); 19 patients were lost to follow-up on July 31, 2008. The mortality rate in the hospital was 14.1% (17/120). The median survival time of ICU survivors was 406 days (range 364 to 448) after ICU discharge, and 33 (27.5%) patients died after discharge from the ICU during follow-up. The survival of patients who were discharged from the ICU is shown in Figures 2 and 3 . Cox multivariate analysis identified the length of stay in the ICU, a CCI score greater than 2, and the need for vasopressors as independent predictors of death after ICU discharge (Table 5 ).
DISCUSSION
Several important findings were obtained in the present study of patients with solid tumours who were admitted to an oncological ICU: 1) The outcomes of patients with solid cancer were comparable to those of the general ICU population, with a 21.5% mortality rate, 2) the independent prognostic factors of in-ICU death were the need for vasopressors and the APCAHe II score, 3) the length of stay in the ICU, a CCI >2 and the need for vasopressors were independent predictors of death after ICU discharge. The present study shows that the outcomes of patients admitted to the ICU with solid tumours has improved significantly based on a comparison with another study 9 and confirms the findings of recent studies on a similar group of cancer patients admitted to the ICU 10, 19 . Azoulay et al 9 reported the outcomes of 120 patients admitted to their ICU with solid tumours over an eight-year study period; the overall 30-day mortality rate was 59% (68 deaths) and 92% of the deaths occurred in the ICU. Mendoza et al 10 determined the outcomes of 147 patients admitted to a medical ICU with solid tumours. A total of 58 (39.4%) patients died in the hospital, with 42 (28.47%) of the deaths occurring in the ICU. Recently, Taccone et al 22 reported a sub-study of the prospective, multi-centre, observational Sepsis Occurrence in the Acutely Ill Patients (SOAP) study 23 , which did not focus specifically on cancer patients but included 473 patients with a malignancy. Of these, 404 patients (85%) had solid tumours. The mortality rate of the subgroup of critically ill patients with solid tumours was 20%. In our cohort of patients admitted to the ICU with solid tumours, the mortality rate was 21.5%, similar to that reported by Mendoza et al 10 and Taccone et al 22 . These trends toward improved overall survival of critically ill cancer patients may be the result of a better selection of cancer patients for intensive care, the availability of new drugs and recent advances in diagnostic and therapeutic strategies in critically ill patients, which have led to the better management of specific diseases in the ICU.
Our multivariate analysis identified two independent parameters associated with ICU death: the PeeP and APACHe II score.
Acute respiratory failure requiring MV is probably the most frequent reason for ICU admission in cancer patients 24, 25 . Different studies have included haematological diseases and solid tumours, without differentiating between the two groups, and have found MV to be an independent adverse predictor of outcome in cancer patients admitted to the ICU 2, 5, 24, 26, 27 . Azoulay et al 9 reported an OR of 3.5 for death within 30 days in patients with solid tumours who required MV, the most potent prognostic factor. In a more recent report, MV was described by Taccone et al 22 as an independent prognostic factor for hospital mortality in 404 patients with solid cancer (OR 2.4, 95% CI 1.2 to 4.7, P=0.015). Mendoza et al 10 studied 147 critically ill patients with solid tumours and reported that the requirement for MV (49% in survivors versus 51% in non-survivors) was not predictive of mortality. In our study, similar to the report by Mendoza et al 10 , the need for MV was not predictive of mortality in the ICU in the multivariate analysis unless there was a need for PeeP (per 1 cm H 2 O increase), although the methodology used for the data analysis was different. Soares et al 28 reported 463 cancer patients who were ventilated for more than 24 hours, including 359 (78%) with solid tumours and 104 (22%) with haematological malignancies. The ICU and hospital mortality rates in these patient groups were 50 and 64%, respectively. In contrast, the mortality rate for patients requiring MV in our study was 26.2% (37/141). This is in agreement with results published by Kongsgaard and Meidell 29 , in which the overall mortality for 119 ICU patients requiring MV was 29%. This may be related to improvements in lung-protective ventilation strategies that minimise further lung injury, the use of a multidisciplinary approach to patient management, and improvements in the therapeutic options for patients with solid tumours. Comparisons with data from other publications are difficult because most patients included in other studies were treated for haematological malignancies, which are associated with poor outcomes 2, 5, 24, 29 , and another study did not focus specifically on cancer patients.
The APACHe II score has been used with varying success to predict outcomes in cancer patients. In a study of 52 breast cancer patients, APACHe II scores were independently associated with survival outcomes in patients admitted to the ICU 30 . Chang et al evaluated the predictive accuracy of the APACHe II score for severity of illness in 1263 cancer patients who were admitted to the ICU 31 . The APACHe II scores were predictive of hospital mortality in critically ill cancer patients. On the other hand, den Boer et al reported that the general prognostic models for ICU patients generally underestimate the risk of dying for cancer patients admitted to the ICU 4 . Our results indicate that APACHe II score determined using the worst score for acute physiological variables in the first 24 hours of ICU admission can be considered to estimate outcomes in critically ill patients with solid tumours.
Comorbid illnesses have shown increasing importance as a prognostic factor for survival and treatment-related outcomes in oncology. Among the methods used to measure comorbidity, CCI score 12 is the most widely used to date. The CCI has demonstrated excellent predictive ability for a variety of clinical outcomes, as well as numerous malignancies [33] [34] [35] . We found that a CCI score greater than 2 in the follow-up period was an independent predictor of death after ICU discharge, and the risk of death was significantly higher in patients with a CCI score greater than 2. Our study has some limitations criTicAlly ill pATienTS wiTH Solid TumourS in icu Anaesthesia and Intensive Care, Vol. 38, No. 2, March 2010 in that it only included cancer patients admitted to a single oncological ICU and represents the experience of a single centre.
CONClUSIONS
The present study shows that the ICU outcomes of patients with solid tumours are improving and are comparable to other critically ill patient populations, confirming the current trend toward a decrease in the mortality of cancer patients. The independent prognostic factors for in-ICU death were the need for vasopressors and the APCAHe II score, while the length of stay in the ICU, a CCI score greater than 2 and the need for vasopressors were independent predictors of death after ICU discharge.
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